Evidence map›Paper›PMID 36533751›Full record

ArticleActa bio-medica : Atenei Parmensis2022

Intermediate products of purine metabolism in an experimental model of pancreatic necrosis.

Grigoriy Abramov, Yelena Pozdnyakova, Neila Tankibaeva, Kairat Shakeev, Maida Tusupbekova, Dmitriy Shestakov

Open access · greenAbstract read
In one paragraph

Article in Acta bio-medica : Atenei Parmensis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Grigoriy AbramovKaraganda Medical University. doctar-g@mail.ru.
Yelena PozdnyakovaDepartment of Biomedicine, Karaganda Medical University. nike_anteros@mail.ru.
Neila TankibaevaKaraganda Medical University. neila_tan@mail.ru.
Kairat ShakeevKaraganda Medical University. kara3007@mail.ru.
Maida TusupbekovaKaraganda Medical University. maida@mail.ru.
Dmitriy ShestakovKaraganda Medical University. dshestakov008@gmail.com.
Karaganda Medical University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimDetermine the level of purines in the blood plasma of experimental animals at three stages of induced pancreatic necrosis. Find out the potential of purines as predictors of the severity of pancreatitis.

methodsThe experiment was carried out on white outbred rabbits. The pancreatic necrosis was modeled by introducing self-bile into the pancreatic parenchyma. The pancreas of rabbits, after isolation, was subjected to microscopic description. Blood was also taken from rabbits to determine the plasma levels of adenine, guanine, hypoxanthine, xanthine, and uric acid.

results12 hours after the administration of self-bile, the level of xanthine significantly increases and the concentration of uric acid in the blood plasma increases by 3 times. 24 hours after the introduction of self-bile, there is a slight decrease in the level of adenine, xanthine and uric acid, and the indicators of purine metabolism remain elevated. 48 hours after the introduction of self-bile, the levels of guanine, hypoxanthine and xanthine are reduced.

conclusionsThe concentration indices of absolute and relative intermediate products of purine metabolism were increased at the initial stage of pancreatic necrosis. The activity of enzymes and metabolites of purine metabolism involved in the formation of reactive oxygen species and free radicals increased. The hypothesis that intermediate products of purine metabolism can be predictors of pancreatic necrosis was confirmed.

Indexed as

Pancreatitis, Acute NecrotizingUric AcidAdenineAnimalsGuanineHypoxanthineModels, TheoreticalPurinesRabbitsXanthineAdenineGuanineHypoxanthinePurinesUric AcidXanthine

Identifiers

PMID36533751
PMCPMC9828892
OpenAlexW4312113890

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.